Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: July 26, 2007
Reporting Period: Second Quarter of 2007
This filing serves as a notification that the Company issued a press release announcing its financial results for the second quarter of 2007. The actual financial data is contained in the press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2), which are incorporated by reference but not reproduced in the text of this 8-K.
Key Financial Metrics
The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release and supplemental information.
Material Changes
No material changes or comparative financial data are detailed within the body of this filing. The document solely announces the availability of the Q2 2007 results.
Guidance, Outlook, and Risks
This filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. Such information is expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 26, 2007) for specific Q2 2007 revenue and earnings figures.
- Access Exhibit 99.2 (Supplemental Information) for additional financial details not included in the press release.
- Verify the Company's website (www.bms.com) for the full text of the supplemental information referenced in the filing.
- Compare Q2 2007 results against Q2 2006 figures once the press release is obtained to assess year-over-year performance.